AMOREPACIFIC CORPORATION
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- -
- Established
- 2006-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
23
Active:0
Completed:21
Trial Phases
4 Phases
Phase 1:4
Phase 2:7
Phase 3:1
+1 more phases
Drug Approvals
48
CANADA:24
Drug Approvals
- Prev
- 1
- 2
- 3
- Next
Clinical Trials
Distribution across different clinical trial phases (23 trials with phase data)• Click on a phase to view related trials
Not Applicable
11 (47.8%)Phase 2
7 (30.4%)Phase 1
4 (17.4%)Phase 3
1 (4.3%)Clinical Study to Evaluate the Body Fat Reducing Effects of Heat-Treated Green Tea Extract Complex
Not Applicable
Recruiting
- Conditions
- Body Fat
- First Posted Date
- 2024-09-24
- Last Posted Date
- 2024-09-24
- Lead Sponsor
- Amorepacific Corporation
- Target Recruit Count
- 100
- Registration Number
- NCT06609603
- Locations
- 🇰🇷
Catholic University St. Vincent Hospital, Suwon, Gyeonggi-do, Korea, Republic of
Clinical Study to Evaluate the Effects and Safety of Green Tea Extract on Blood Glucose Regulation
Not Applicable
Recruiting
- Conditions
- Blood Sugar
- First Posted Date
- 2024-09-12
- Last Posted Date
- 2024-09-12
- Lead Sponsor
- Amorepacific Corporation
- Target Recruit Count
- 84
- Registration Number
- NCT06592365
- Locations
- 🇰🇷
Kangbuk samsung hospital, Seoul, Korea, Republic of
🇰🇷Seoul National Universtiy Hospital, Seoul, Korea, Republic of
🇰🇷The Catholic University of Korea St. Vincent's Hospital, Seoul, Korea, Republic of
Evaluated the Efficacy and Safety of APCP on Hair Health
Not Applicable
Completed
- Conditions
- Hair Damage
- First Posted Date
- 2024-05-20
- Last Posted Date
- 2024-05-22
- Lead Sponsor
- Amorepacific Corporation
- Target Recruit Count
- 150
- Registration Number
- NCT06422026
- Locations
- 🇰🇷
Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of
Clinical Study to Evaluate the Body Fat Reducing Effect and Safety of GTB1
Not Applicable
Completed
- Conditions
- Body Fat
- First Posted Date
- 2024-05-20
- Last Posted Date
- 2024-05-22
- Lead Sponsor
- Amorepacific Corporation
- Target Recruit Count
- 100
- Registration Number
- NCT06422013
- Locations
- 🇰🇷
Jeonbuk National University Hospital, Jeonju, Jeollabuk-do, Korea, Republic of
Clinical Trial to Evaluate of Efficacy and Safety of Ginsengberry Concentrate on Fatigue.
Not Applicable
Completed
- Conditions
- Fatigue
- First Posted Date
- 2023-02-13
- Last Posted Date
- 2023-05-26
- Lead Sponsor
- Amorepacific Corporation
- Target Recruit Count
- 88
- Registration Number
- NCT05725044
- Locations
- 🇰🇷
Inha University Hospital, Incheon, Korea, Republic of
- Prev
- 1
- 2
- 3
- 4
- 5
- Next
News
No news found